Sinopsis
New and exciting data presented each day during the conference and address the potential impact on current clinical practice.
Episodios
-
![Advancing the Management of Insomnia: Diagnostic and Therapeutic Strategies for Success Sleep Disorders Psychopharmacology - Karl Doghramji, MD and David N. Neubauer, MD]()
Advancing the Management of Insomnia: Diagnostic and Therapeutic Strategies for Success Sleep Disorders; Psychopharmacology - Karl Doghramji, MD and David N. Neubauer, MD
01/11/2019 Duración: 01h22minThis webcast examines the clinical evidence surrounding emerging insomnia pharmacotherapeutic strategies for informed integration into therapeutic decision-making.
-
![Addressing the National Burden of Adult ADHD: Combining Live Patient Perspectives with Best Practice Strategies for Improved Identification and Treatment - Rakesh Jain, MD, MPH and C. Brendan Montano, MD]()
Addressing the National Burden of Adult ADHD: Combining Live Patient Perspectives with Best Practice Strategies for Improved Identification and Treatment - Rakesh Jain, MD, MPH and C. Brendan Montano, MD
01/11/2019 Duración: 01h26minThis webcast discusses best practices for incorporating patient-appropriate stimulant pharmacotherapy and evidence-based strategies supporting medication adherence into individualized treatment plans for adult patients with ADHD.
-
![Clinical Challenges in MDD: Addressing the Needs of Patients with Comorbid Disorders - W. Clay Jackson, MD, DipTh Rakesh Jain, MD, MPH Charles L. Raison, MD]()
Clinical Challenges in MDD: Addressing the Needs of Patients with Comorbid Disorders - W. Clay Jackson, MD, DipTh; Rakesh Jain, MD, MPH; Charles L. Raison, MD
01/11/2019 Duración: 01h10minThis webcast evaluates current strategies for the pharmacotherapeutic treatment of comorbid and mixed MDD, as well as agents under investigation for these co-occurring disorders.
-
![Addressing Patient Adherence in Bipolar Disorder 1: Managing Comorbidities and Increasing Functional Ability - W. Clay Jackson, MD, DipTh Vladimir Maletic, MD, MS Charles L. Raison, MD]()
Addressing Patient Adherence in Bipolar Disorder 1: Managing Comorbidities and Increasing Functional Ability - W. Clay Jackson, MD, DipTh; Vladimir Maletic, MD, MS; Charles L. Raison, MD
01/11/2019 Duración: 01h22minThis webcast outlines practical clinical strategies for management of BD comorbidities including substance use disorder, obesity, diabetes, and cardiovascular disease across treatment team.
-
![The Monster Under the BED: Revealing Binge Eating Disorder from a Clinical and a Patient Perspective - Leslie Citrome, MD, MPH and C. Brendan Montano, MD]()
The Monster Under the BED: Revealing Binge Eating Disorder from a Clinical and a Patient Perspective - Leslie Citrome, MD, MPH and C. Brendan Montano, MD
01/11/2019 Duración: 01h24minThis webcast provides a comprehensive understanding of currently available, and pharmacotherapies in development, as well as psychosocial strategies to improve long-term patient outcomes.
-
![The Benefits and Cost-Effectiveness of SGLT2 Inhibitors in T2DM Care - Susan Cornell, PharmD, CDE, FAPhA, FAADE and Jeffrey D. Dunn, PharmD, MBA]()
The Benefits and Cost-Effectiveness of SGLT2 Inhibitors in T2DM Care - Susan Cornell, PharmD, CDE, FAPhA, FAADE and Jeffrey D. Dunn, PharmD, MBA
01/11/2019 Duración: 41minThis webcast examines system-level strategies to increase the achievement of adequate glycemic control, including patient- and provider-targeted education, formulary recommendations, and efforts to promote guideline concordant diabetes management.
-
![Case Discussion on Immunotherapy for Advanced Hepatocellular Carcinoma - Tanios Bekaii-Saab, MD, FACP]()
Case Discussion on Immunotherapy for Advanced Hepatocellular Carcinoma - Tanios Bekaii-Saab, MD, FACP
31/10/2019 Duración: 08minMaking Progress in Advanced Hepatocellular Carcinoma with Targeted Agents: Considerations for Therapeutic Selection, Toxicity Management, and Sequencing
-
![Novel Agents and Targets in Biliary Cancer - Ghassan Abou-Alfa, MD, MBA]()
Novel Agents and Targets in Biliary Cancer - Ghassan Abou-Alfa, MD, MBA
31/10/2019 Duración: 19minMaking Progress in Advanced Hepatocellular Carcinoma with Targeted Agents: Considerations for Therapeutic Selection, Toxicity Management, and Sequencing
-
![Hepatocellular Carcinoma: Managing Adverse Events with New Therapeutic Approaches - Pashtoon M. Kasi, MD, MS]()
Hepatocellular Carcinoma: Managing Adverse Events with New Therapeutic Approaches - Pashtoon M. Kasi, MD, MS
31/10/2019 Duración: 12minMaking Progress in Advanced Hepatocellular Carcinoma with Targeted Agents: Considerations for Therapeutic Selection, Toxicity Management, and Sequencing
-
![Case Discussion: Immunotherapy for Advanced HCC - Tanios Bekaii-Saab, MD, FACP]()
Case Discussion: Immunotherapy for Advanced HCC - Tanios Bekaii-Saab, MD, FACP
31/10/2019 Duración: 08minExploring the Evolving Role of Immunotherapy in Advanced Hepatocellular Carcinoma: Considerations for Therapeutic Selection, Toxicity Management, and Sequencing
-
![Biliary Cancer: Novel Agents and Targets - Ghassan Abou-Alfa, MD, MBA]()
Biliary Cancer: Novel Agents and Targets - Ghassan Abou-Alfa, MD, MBA
31/10/2019 Duración: 19minExploring the Evolving Role of Immunotherapy in Advanced Hepatocellular Carcinoma: Considerations for Therapeutic Selection, Toxicity Management, and Sequencing
-
![HCC: Management of Adverse Events with New Therapeutic Approaches - Pashtoon M. Kasi, MD, MS]()
HCC: Management of Adverse Events with New Therapeutic Approaches - Pashtoon M. Kasi, MD, MS
31/10/2019 Duración: 12minExploring the Evolving Role of Immunotherapy in Advanced Hepatocellular Carcinoma: Considerations for Therapeutic Selection, Toxicity Management, and Sequencing
-
![Optimal Sequencing of Agents in HCC in the Era of Immunotherapy and Novel Agents and Targets - Tanios Bekaii-Saab, MD, FACP]()
Optimal Sequencing of Agents in HCC in the Era of Immunotherapy and Novel Agents and Targets - Tanios Bekaii-Saab, MD, FACP
31/10/2019 Duración: 22minExploring the Evolving Role of Immunotherapy in Advanced Hepatocellular Carcinoma: Considerations for Therapeutic Selection, Toxicity Management, and Sequencing
-
![Debate: Optimal Pancreatic Cancer Therapy - Adjuvant FOLFIRINOX - Michael A. Choti, MD]()
Debate: Optimal Pancreatic Cancer Therapy - Adjuvant FOLFIRINOX - Michael A. Choti, MD
31/10/2019 Duración: 12minChemotherapeutic Advances in the Treatment of Pancreatic Adenocarcinoma: Improving Outcomes and Treatment Tolerability
-
![Debate: Optimal Pancreatic Cancer Therapy - Preoperative Chemo/Chemotherapy - Jordan D. Berlin, MD]()
Debate: Optimal Pancreatic Cancer Therapy - Preoperative Chemo/Chemotherapy - Jordan D. Berlin, MD
31/10/2019 Duración: 07minChemotherapeutic Advances in the Treatment of Pancreatic Adenocarcinoma: Improving Outcomes and Treatment Tolerability
-
![Debate: Pre-Op Treatment of Borderline Resectable Pancreatic Cancer - SBRT - Christopher L. Hallemeier, MD]()
Debate: Pre-Op Treatment of Borderline Resectable Pancreatic Cancer - SBRT - Christopher L. Hallemeier, MD
31/10/2019 Duración: 07minChemotherapeutic Advances in the Treatment of Pancreatic Adenocarcinoma: Improving Outcomes and Treatment Tolerability
-
![Debate: Pre-Op Treatment of Borderline Resectable Pancreatic Cancer - Conventional RT - Christopher H. Crane, MD]()
Debate: Pre-Op Treatment of Borderline Resectable Pancreatic Cancer - Conventional RT - Christopher H. Crane, MD
31/10/2019 Duración: 08minChemotherapeutic Advances in the Treatment of Pancreatic Adenocarcinoma: Improving Outcomes and Treatment Tolerability
-
![Gastric Cancer: An Update on First-Line Therapies - David H. Ilson, MD, PhD]()
Gastric Cancer: An Update on First-Line Therapies - David H. Ilson, MD, PhD
31/10/2019 Duración: 22minClosing the Gaps in Gastric Cancer Care: Novel Therapies and Multidisciplinary Strategies
-
![Case Discussion: Individualized Selection and Sequencing of Therapies in the Next-Line Treatmnet of mCRC - Axel Grothey, MD]()
Case Discussion: Individualized Selection and Sequencing of Therapies in the Next-Line Treatmnet of mCRC - Axel Grothey, MD
31/10/2019 Duración: 11minMetastatic Colorectal Cancer: An Individualized Approach to Optimal Treatment Selection and Adverse Events Management
-
![Colorectal Cancer: Sequencing and Therapeutic Approaches in First- and Next-Line Treatment - Axel Grothey, MD]()
Colorectal Cancer: Sequencing and Therapeutic Approaches in First- and Next-Line Treatment - Axel Grothey, MD
31/10/2019 Duración: 25minMetastatic Colorectal Cancer: An Individualized Approach to Optimal Treatment Selection and Adverse Events Management
